16 min listen
Mining Bugs for Drugs
FromThe Bio Report
ratings:
Length:
30 minutes
Released:
Feb 16, 2023
Format:
Podcast episode
Description
The microbial world has been a rich source of medicines, but our ability to explore the full potential of the microbes both in us and around us has been limited by technology and the difficulty of culturing most microbes in a lab. Biosortia Microbiomics has developed a platform for finding, amplifying, and screening microbes as a potential source of novel, small molecule drugs. We spoke to Ross Youngs, CEO and founder of Biosortia, about the case for exploring various microbiomes to discover new small molecule drugs, how the company’s platform technology enables it to investigate a much broader range of microbes, and its business model for capitalizing on the discoveries it makes.
Released:
Feb 16, 2023
Format:
Podcast episode
Titles in the series (100)
Promise Shown in Different Approach to Alzheimer’s: AgeneBio is developing drugs to treat the pre-dementia stage of Alzheimer’s disease, and other neurological and psychiatric conditions. The company announced encouraging mid-stage results for its lead therapeutic, which works by quieting hyperactivit... by The Bio Report